Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{191d54a5951d47eab67886144fe63b36,
title = "Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.",
author = "Mikkel {\O}stergaard and L Jacobsson and C Schaufelberger and Hansen, {Michael Sejer} and J Bijlsma and A Dudek and M Rell-Bakalarska and F Staelens and R Haake and E Sundman-Engberg and Henning Bliddal",
year = "2014",
language = "English",
volume = "73",
pages = "472",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl. 2",

}

RIS

TY - ABST

T1 - Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.

AU - Østergaard, Mikkel

AU - Jacobsson, L

AU - Schaufelberger, C

AU - Hansen, Michael Sejer

AU - Bijlsma, J

AU - Dudek, A

AU - Rell-Bakalarska, M

AU - Staelens, F

AU - Haake, R

AU - Sundman-Engberg, E

AU - Bliddal, Henning

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

VL - 73

SP - 472

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 2

ER -

ID: 44696520